Lead protection prevents DNA damage in TACE operators

Tuesday, December 1 | 1:30 p.m.-2:30 p.m. | T6-SSIR02-5 | Room E353B

Standard radiation safety protocols effectively shielded interventional radiologists from DNA damage during transcatheter arterial chemoembolization (TACE), even as patients in the same procedures sustained measurable DNA damage, according to research in this Tuesday afternoon session.

Takuya Mori, MD, of Hiroshima University in Japan, and colleagues enrolled 12 interventional radiologists who routinely perform TACE and collected peripheral blood samples before and after each procedure. The team quantified γ-H2AX foci — a biomarker for radiation-induced DNA double-strand breaks — in lymphocytes. Operators wore standard lead protective gear and followed protocols including minimized fluoroscopy time and increased distance from the radiation source; 12 TACE patients served as a control group.

Operators showed no significant increase in γ-H2AX foci after procedures (0.46 to 0.53 foci per cell; p = 0.40), despite a mean radiation dose of 69.3 μSv outside the protective garments. Patients showed a significant increase (0.69 to 2.00 foci per cell; p < 0.01). Among factors analyzed, dose-area product and dose-length product were significantly associated with the rise in patient γ-H2AX foci, while age, sex, and BMI were not.

Radiation exposure during IR procedures is a growing concern, the researchers noted, and TACE for hepatocellular carcinoma is widely performed — yet the potential health risks to operators had remained unclear.

“While TACE procedures result in measurable DNA damage in patients, no significant radiation-induced DNA damage was observed in operators, highlighting the effectiveness of current radiation protection measures,” the authors wrote.

Stop by this Tuesday session to hear more about the team’s methodology and what their findings suggest for radiation safety practices in the IR suite.

Page 1 of 1